 Narcotic Antagonists
"Narcotic Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents inhibiting the effect of narcotics on the central nervous system.
| Descriptor ID |
D009292
|
| MeSH Number(s) |
D27.505.696.543 D27.505.696.663.850.512 D27.505.954.427.550
|
| Concept/Terms |
Narcotic Antagonists- Narcotic Antagonists
- Antagonists, Narcotic
- Opioid Receptor Antagonists
- Antagonists, Opioid Receptor
- Receptor Antagonists, Opioid
- Opioid Antagonists
- Antagonists, Opioid
|
Below are MeSH descriptors whose meaning is more general than "Narcotic Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Narcotic Antagonists".
This graph shows the total number of publications written about "Narcotic Antagonists" by people in this website by year, and whether "Narcotic Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1998 | 0 | 1 | 1 | | 1999 | 2 | 2 | 4 | | 2000 | 0 | 1 | 1 | | 2003 | 0 | 2 | 2 | | 2004 | 1 | 1 | 2 | | 2006 | 0 | 1 | 1 | | 2007 | 3 | 1 | 4 | | 2008 | 3 | 0 | 3 | | 2009 | 0 | 2 | 2 | | 2010 | 1 | 0 | 1 | | 2011 | 2 | 1 | 3 | | 2012 | 2 | 2 | 4 | | 2013 | 1 | 2 | 3 | | 2014 | 1 | 1 | 2 | | 2015 | 2 | 4 | 6 | | 2016 | 2 | 2 | 4 | | 2017 | 2 | 1 | 3 | | 2018 | 5 | 2 | 7 | | 2019 | 8 | 8 | 16 | | 2020 | 5 | 4 | 9 | | 2021 | 3 | 3 | 6 | | 2022 | 0 | 7 | 7 | | 2023 | 1 | 3 | 4 | | 2024 | 5 | 10 | 15 | | 2025 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Narcotic Antagonists" by people in Profiles.
-
Bredenberg E, Olsen H, Ladka M, Beekman K, Black JC, Ellis MS, Monte AA. People entering opioid substance use treatment have low rates of naloxone knowledge and possession. Drug Alcohol Depend. 2025 Jun 01; 271:112645.
-
McCabe DJ, Gibbs H, Pratt AA, Culbreth R, Sutphin AM, Abston S, Li S, Wax P, Brent J, Campleman S, Aldy K, Falise A, Manini AF. Risk of Delayed Intubation After Presumed Opioid Overdose in the Emergency Department. Ann Emerg Med. 2025 Jun; 85(6):498-504.
-
Iscoe MS, Diniz Hooper C, Levy DR, Buchanan L, Dziura J, Meeker D, Taylor RA, D'Onofrio G, Oladele C, Sarpong DF, Paek H, Wilson FP, Heagerty PJ, Delgado MK, Hoppe J, Melnick ER. Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial. BMJ Open. 2025 Feb 20; 15(2):e098072.
-
Fine DR, Critchley N, Hart K, Regan S, Sporn N, Gaeta J, Wright J, Kruse G, Baggett TP. Buprenorphine adherence among a prospective cohort of homeless-experienced adults with opioid use disorder. Drug Alcohol Depend. 2025 May 01; 270:112598.
-
Dicker F, Lothet E, Schwarz E, Aldy K, Brent J, Wax P, Culbreth R, Campleman S, Krotulski A, Logan B, Amaducci A, Judge B, Levine M, Calello D, Shulman J, Hughes A, Hendrickson RG, Meaden CW, Manini AF. Tramadol as a fentanyl adulterant: Prevalence and management in a ToxIC Fentalog study prospective cohort. Am J Emerg Med. 2025 Mar; 89:169-173.
-
Aldy K, Krotulski A, Brent J, Campleman S, Culbreth R, Logan B, Wax P, Amaducci A, Judge B, Levine M, Schwarz E, Calello DP, Meaden CW, Shulman J, Hughes A, Hendrickson R, Carpenter J, Buchanan J, Manini AF. Emergency Department Patients with Para-Fluorofentanyl Overdose. J Emerg Med. 2025 May; 72:56-69.
-
Krumheuer A, Janke AT, Nickel A, Kim E, Bailes C, Ager EE, Purington EK, Mahmood SM, Hooyer M, Ryan ML, Baker JE, Purdy M, Greineder CF, Commissaris CV, Smith SN, Fung CM, Losman ED. Implementation of an Emergency Department Opioid Use Disorder Initiative: Clinical Processes and Institution Specific Education Improve Care. J Emerg Med. 2025 Apr; 71:104-113.
-
Sommers SW, Tolle HJ, Trinkley KE, Johnston CG, Dietsche CL, Eldred SV, Wick AT, Hoppe JA. Clinical Decision Support to Increase Emergency Department Naloxone Coprescribing: Implementation Report. JMIR Med Inform. 2024 Nov 06; 12:e58276.
-
Y Bernstein E, Magane KM, Dukes KA, Palfai TP, Lee JH, Saitz R, Samet JH. Correlates of post-hospitalization naltrexone adherence for alcohol use disorder. Drug Alcohol Depend. 2024 Dec 01; 265:112470.
-
Castry M, Tin Y, Feder NM, Lewis N, Chatterjee A, Rudorf M, Samet JH, Beers D, Medley B, Gilbert L, Linas BP, Barocas JA. An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder. J Subst Use Addict Treat. 2024 Dec; 167:209517.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|